74 results
IBS-D Pharmacotherapy

Loperamide
Rifaximin
Eluxadoline
Alosetron
Antispasmodics
Tricyclic antidepressants
SSRIs

#IBSD #IBS #Diarrhea #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
IBS-D Pharmacotherapy ... #IBS #Diarrhea ... Bowel #Syndrome #pharmacology ... table #comparison #management ... #treatment
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... Aspergillosis #Treatment ... #management #pharmacology ... #IDSA
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Osteomyelitis - IDSA ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
Perianal Crohn's Disease - IBD Algorithm

 • 5-40% w perianal fistula
 • ↑ risk if colonic
Crohn's Disease - IBD ... refractory to medical ... #IBDAlgorithm #IBD ... gastroenterology #management ... #treatment
IBS-C Pharmacotherapy

Polyethylene glycol
Lubiprostone
Linaclotide
Plecanatide
Tegaserod
Tenapanor

#IBSC #IBS #Constipation #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
IBS-C Pharmacotherapy ... Tenapanor #IBSC #IBS ... Bowel #Syndrome #pharmacology ... table #comparison #management ... #treatment
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Pearls: • IDA ... Receptor (sTfR) to differentiate ... IDA vs. ... improvement w/ mental ... Algorithm #diagnosis #management
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... Tuberculosis #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... #Antibiotics #Treatment ... #Regimen #Management ... #Guidelines #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... immunocompromised, IBD ... (IDSA 2021): ... /severe CDI IDSA ... 2021 CDI Treatment